Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer

SIMPLE SUMMARY: The HER2 status of breast cancers is accurately determined by measuring HER2 protein overexpression and gene amplification. However, these clinical diagnostic tests cannot predict the response to therapy. Single molecule imaging approaches can quantify molecular features of HER2, suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Maddox, Adam L., Brehove, Matthew S., Eliato, Kiarash R., Saftics, Andras, Romano, Eugenia, Press, Michael F., Mortimer, Joanne, Jones, Veronica, Schmolze, Daniel, Seewaldt, Victoria L., Jovanovic-Talisman, Tijana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179327/
https://www.ncbi.nlm.nih.gov/pubmed/35681773
http://dx.doi.org/10.3390/cancers14112795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179327/
https://www.ncbi.nlm.nih.gov/pubmed/35681773
http://dx.doi.org/10.3390/cancers14112795

Ejemplares similares